News from NORD

NIH Workshop Focuses on Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis


 

NIH recently hosted a workshop to bring researchers together to discuss severe drug reactions such as Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis and possible genetic factors that might predispose individuals to greater risk.

Recommended Reading

Applications Are Being Accepted for Free Family Rare Disease Summer Camp
MDedge Endocrinology
Largest-Ever Study of Pemphigus and Pemphigoid Launched
MDedge Endocrinology
Pamela Gavin of NORD to Speak at Technology and Rare Neurological Diseases Symposium
MDedge Endocrinology
Foundation for Prader-Willi Research Promotes Awareness of Guidelines Related to Use of Human Growth Hormone
MDedge Endocrinology
DTC genetic health risk tests: Beware
MDedge Endocrinology
For girls with Turner syndrome, experimental fertility preservation may offer the hope of a baby of their own
MDedge Endocrinology
Cushing’s appears to begin its cardiovascular effects during childhood
MDedge Endocrinology
Patient Advocacy Groups Oppose AHCA
MDedge Endocrinology
NORD Issues RFPs for 2017 Research Grants for Study of Rare Diseases
MDedge Endocrinology
NORD Rare Action Network Issues Spring 2017 State Policy Legislative Tracker
MDedge Endocrinology